Nang Kuang Pharmaceutical Co., Ltd. announced that the Abbreviated New Drug Application (ANDA) for Pemetrexed for Injection indicated for the treatment of lung cancer has been final approved by the U.S. Food and Drug Administration (FDA). The drug will be immediately launched in the U.S. to increase the revenue.